EyePoint Pharmaceuticals
EYPT
#5174
Rank
โ‚น136.43 B
Marketcap
โ‚น1,648
Share price
3.16%
Change (1 day)
119.95%
Change (1 year)

Market capitalization of EyePoint Pharmaceuticals (EYPT)

Market cap: โ‚น136.43 Billion

As of December 2025 EyePoint Pharmaceuticals has a market cap of โ‚น136.43 Billion. This makes EyePoint Pharmaceuticals the world's 5174th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of EyePoint Pharmaceuticals from 2005 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น136.43 B223.65%
2024โ‚น42.15 B-55.13%
2023โ‚น93.96 B851.85%
2022โ‚น9.87 B-68.04%
2021โ‚น30.88 B324.17%
2020โ‚น7.28 B-39.8%
2019โ‚น12.09 B-4.04%
2018โ‚น12.60 B303.85%
2017โ‚น3.12 B-21.42%
2016โ‚น3.97 B-58.15%
2015โ‚น9.49 B23.87%
2014โ‚น7.66 B14.43%
2013โ‚น6.69 B333.8%
2012โ‚น1.54 B26.36%
2011โ‚น1.22 B-71.21%
2010โ‚น4.24 B38.28%
2009โ‚น3.06 B271.9%
2008โ‚น0.82 B3543.11%
2007โ‚น22.64 M-34.39%
2006โ‚น34.52 M-99.63%
2005โ‚น9.40 B

End of Day market cap according to different sources

On Dec 7th, 2025 the market cap of EyePoint Pharmaceuticals was reported to be:

โ‚น132.26 Billion
by Nasdaq info icon info icon
โ‚น132.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NRC Health
NRC
โ‚น32.75 B-75.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
โ‚น1.64 B-98.80% Bahamas